Myelofibrosis Transformation in Essential Thrombocythemia

6 clinical trials · Condition

Record	Firm	Date
Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis (NCT07750574)	Chengdu Zenitar Biomedical Technology Co., Ltd	2026-11-01
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) (NCT07362225)	MPN Research Foundation	2025-09-26
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis (NCT04517851)	M.D. Anderson Cancer Center	2021-02-10
PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT04054245)	M.D. Anderson Cancer Center	2019-07-24
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis (NCT02421354)	M.D. Anderson Cancer Center	2015-05-14
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT01787487)	M.D. Anderson Cancer Center	2013-03-13

Every clearance here is in the API, with alerts when new ones post.